AstraZeneca PLC (ZEG)
FSX
Closed
Oct 7, 2026
Day's Range
138.9052 wk Range
134.00Overview - ZEG - AstraZeneca PLC
Key Statistics
Valuation
Enterprise Value
222.12B
P/E (Trailing)
‪24.96‬
PEG Ratio
‪13.14‬
Price / Sales (TTM)
‪3.67‬
Price / Book
‪5.43‬
EV / EBITDA
‪12.72‬
Profitability
Gross Margin
‪83.59%‬
Profit Margin
‪17.02%‬
Operating Margin
‪23.45%‬
Return on Assets
‪8.01%‬
Return on Equity
‪21.96%‬
Ownership
Shares Outstanding
1.55B
Float
1.54B
Held by Insiders
‪0.05%‬
Held by Institutions
‪64.93%‬
Price stats
Beta
‪0.20‬
50-Day Avg
‪142.58‬
200-Day Avg
‪157.67‬
Dividends
Payout Ratio
‪47.41%‬
Frequency
Semi-Annual
Market Cap - ZEG - AstraZeneca PLC
Peers - ZEG - AstraZeneca PLC
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on FSX.
Profile Summary - ZEG - AstraZeneca PLC
About
AstraZeneca PLC is a global biopharmaceutical company that discovers, develops, manufactures, and commercializes prescription medicines. AstraZeneca PLC focuses on major therapeutic areas including oncology, rare diseases, cardiovascular, renal and metabolism, respiratory and immunology, and vaccines and immune…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
